Growth equity fund research profile
Faering Capital India Evolving Fund III is an India-focused growth-equity vehicle backing mid-market companies across financial services, consumer, healthcare, logistics and consumption-enabling businesses. IFC's fund disclosure identifies the vehicle, its investment manager and a current investee schedule, making it separately auditable from the broader Faering manager record.
At a glance
Research profile
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Faering Capital India Evolving Fund III uses a growth equity approach across Consumer, financial services, healthcare, logistics.
Current evidence
The IFC disclosure for Faering Capital India Evolving Fund III lists twelve India investees as of January 1, 2025, including Plum, Anthem Biosciences, BookMyForex, CAMS, Finova Capital, Go Digit Insurance, Max Bupa Health Insurance, Nykaa, Prataap, Utkarsh CoreInvest and WheelsEMI. The manager's current AIF disclosures continue to identify Fund III as an India vehicle managed by Faering Capital.
Strategy
Growth equity
Sector focus
Consumer, financial services, healthcare, logistics
AIF structure context
Indian private equity, growth, buyout and many real-asset strategies are commonly structured as Category II AIFs. Verify the specific vehicle and registration before investing.
Current signal
The IFC disclosure for Faering Capital India Evolving Fund III lists twelve India investees as of January 1, 2025, including Plum, Anthem Biosciences, BookMyForex, CAMS, Finova Capital, Go Digit Insurance, Max Bupa Health Insurance, Nykaa, Prataap, Utkarsh CoreInvest and WheelsEMI. The manager's current AIF disclosures continue to identify Fund III as an India vehicle managed by Faering Capital.
Investor questions
Faering Capital India Evolving Fund III is covered in Rupeia's private equity research universe. The current public record describes the strategy as Growth equity, with a sector focus of Consumer, financial services, healthcare, logistics. The profile should be read with the linked source trail and Typical route: Category II AIF context.
The profile displays only company or asset names attributable to Faering Capital India Evolving Fund III in the reviewed public sources: Plum, Anthem Biosciences, BookMyForex, CAMS, Finova Capital, Go Digit Insurance, Max Bupa Health Insurance, Nykaa, Plum Goodness, Prataap, Utkarsh CoreInvest, WheelsEMI. It does not represent a complete current portfolio unless the manager has published one.
IFC's private-equity fund disclosure lists twelve India investees as of January 1, 2025. Fund-level realised returns and current DPI/MOIC are not publicly disclosed. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.
Public fund size: The fund sought US$200 million with a US$250 million hard cap; the GP's current AIF disclosures identify India Evolving Fund III but do not publish a current audited NAV or return schedule.. Public terms or access information: Growth equity in Indian mid-market companies across consumer, financial services, healthcare, logistics and consumption-enabling sectors; fees, carry, ownership and reserves are not publicly disclosed.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.
The current source record names Aditya Parekh (Managing Partner); Sameer Shroff (Co-Founder). Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.
Review entry valuation, leverage, governance rights, concentration, execution of the value-creation plan and exit timing. The current open diligence point is: Fund-level realised returns, current NAV and vehicle-level net performance are not publicly disclosed..
2025-01-01: The IFC disclosure for Faering Capital India Evolving Fund III lists twelve India investees as of January 1, 2025, including Plum, Anthem Biosciences, BookMyForex, CAMS, Finova Capital, Go Digit Insurance, Max Bupa Health Insurance, Nykaa, Prataap, Utkarsh CoreInvest and WheelsEMI. The manager's current AIF disclosures continue to identify Fund III as an India vehicle managed by Faering Capital.
Next step
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.